ATE195516T1 - Substituierte phenylverbindungen als endothelinantagoniste - Google Patents
Substituierte phenylverbindungen als endothelinantagonisteInfo
- Publication number
- ATE195516T1 ATE195516T1 AT96900634T AT96900634T ATE195516T1 AT E195516 T1 ATE195516 T1 AT E195516T1 AT 96900634 T AT96900634 T AT 96900634T AT 96900634 T AT96900634 T AT 96900634T AT E195516 T1 ATE195516 T1 AT E195516T1
- Authority
- AT
- Austria
- Prior art keywords
- aryl
- heteroaryl
- optionally substituted
- substituted phenyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9501635.8A GB9501635D0 (en) | 1995-01-27 | 1995-01-27 | Chemical compounds |
GBGB9504061.4A GB9504061D0 (en) | 1995-03-01 | 1995-03-01 | Chemical compounds |
GBGB9509604.6A GB9509604D0 (en) | 1995-05-11 | 1995-05-11 | Chemical compounds |
PCT/GB1996/000120 WO1996022978A1 (en) | 1995-01-27 | 1996-01-22 | Substituted phenyl compounds as endothelin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE195516T1 true ATE195516T1 (de) | 2000-09-15 |
Family
ID=27267564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96900634T ATE195516T1 (de) | 1995-01-27 | 1996-01-22 | Substituierte phenylverbindungen als endothelinantagoniste |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0805802B1 (de) |
JP (1) | JP3901729B2 (de) |
KR (1) | KR19980701690A (de) |
AT (1) | ATE195516T1 (de) |
AU (1) | AU706940B2 (de) |
BR (1) | BR9606961A (de) |
CA (1) | CA2211646C (de) |
CZ (1) | CZ223697A3 (de) |
DE (1) | DE69609812D1 (de) |
EA (1) | EA000061B1 (de) |
FI (1) | FI973111A (de) |
HU (1) | HUP9801938A3 (de) |
IL (1) | IL116907A0 (de) |
MX (1) | MX9705649A (de) |
NO (1) | NO973441L (de) |
NZ (1) | NZ298853A (de) |
PL (1) | PL184060B1 (de) |
WO (1) | WO1996022978A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
ATE257706T1 (de) | 1997-09-26 | 2004-01-15 | Abbott Gmbh & Co Kg | Endothelin antagonist und renin-angiotensin system hemmer als kombinationspräparate |
DE19743142A1 (de) * | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
DE19743143A1 (de) * | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
AU3011299A (en) * | 1998-03-23 | 1999-10-18 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
BR0309808A (pt) * | 2002-05-07 | 2005-03-01 | Altana Pharma Ag | Combinação para o tratamento de distúrbios das vias aéreas |
PL373000A1 (en) * | 2002-05-07 | 2005-08-08 | Altana Pharma Ag | Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2141197T3 (es) * | 1993-03-19 | 2000-03-16 | Merck & Co Inc | Derivados del acido fenoxifenilacetico. |
-
1996
- 1996-01-22 EA EA199700147A patent/EA000061B1/ru not_active IP Right Cessation
- 1996-01-22 WO PCT/GB1996/000120 patent/WO1996022978A1/en not_active Application Discontinuation
- 1996-01-22 JP JP52270896A patent/JP3901729B2/ja not_active Expired - Lifetime
- 1996-01-22 DE DE69609812T patent/DE69609812D1/de not_active Expired - Lifetime
- 1996-01-22 EP EP96900634A patent/EP0805802B1/de not_active Expired - Lifetime
- 1996-01-22 PL PL96321545A patent/PL184060B1/pl unknown
- 1996-01-22 HU HU9801938A patent/HUP9801938A3/hu unknown
- 1996-01-22 CZ CZ972236A patent/CZ223697A3/cs unknown
- 1996-01-22 BR BR9606961A patent/BR9606961A/pt unknown
- 1996-01-22 CA CA002211646A patent/CA2211646C/en not_active Expired - Lifetime
- 1996-01-22 AU AU44541/96A patent/AU706940B2/en not_active Expired
- 1996-01-22 KR KR1019970705086A patent/KR19980701690A/ko not_active Application Discontinuation
- 1996-01-22 NZ NZ298853A patent/NZ298853A/en unknown
- 1996-01-22 AT AT96900634T patent/ATE195516T1/de not_active IP Right Cessation
- 1996-01-25 IL IL11690796A patent/IL116907A0/xx unknown
-
1997
- 1997-07-25 MX MX9705649A patent/MX9705649A/es unknown
- 1997-07-25 FI FI973111A patent/FI973111A/fi unknown
- 1997-07-25 NO NO973441A patent/NO973441L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NZ298853A (en) | 1998-07-28 |
HUP9801938A2 (hu) | 1999-05-28 |
MX9705649A (es) | 1998-07-31 |
KR19980701690A (ko) | 1998-06-25 |
CZ223697A3 (en) | 1997-12-17 |
PL184060B1 (pl) | 2002-08-30 |
CA2211646A1 (en) | 1996-08-01 |
WO1996022978A1 (en) | 1996-08-01 |
CA2211646C (en) | 2008-09-09 |
FI973111A (fi) | 1997-09-25 |
JPH10513158A (ja) | 1998-12-15 |
NO973441D0 (no) | 1997-07-25 |
EA199700147A1 (ru) | 1997-12-30 |
NO973441L (no) | 1997-09-15 |
BR9606961A (pt) | 1997-11-04 |
EA000061B1 (ru) | 1998-04-30 |
EP0805802B1 (de) | 2000-08-16 |
DE69609812D1 (de) | 2000-09-21 |
EP0805802A1 (de) | 1997-11-12 |
PL321545A1 (en) | 1997-12-08 |
JP3901729B2 (ja) | 2007-04-04 |
HUP9801938A3 (en) | 1999-10-28 |
IL116907A0 (en) | 1996-05-14 |
FI973111A0 (fi) | 1997-07-25 |
AU4454196A (en) | 1996-08-14 |
AU706940B2 (en) | 1999-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE37375T1 (de) | Phosphonyl-hydroxyacyl-aminosaeure-derivate und ihre verwendung als antihypertensiva. | |
ATE219077T1 (de) | Endothelin antagoniste | |
NO965125D0 (no) | Heterosykliske forbindelser med tachykininreseptor-antagonistaktivitet, deres fremstilling og anvendelse | |
ATE239477T1 (de) | Chinolone und deren therapeutische verwendung | |
DE69713582D1 (de) | Zimtsäurederivate und deren verwendung als integrin-antagonisten | |
DE60023318D1 (de) | Heteropolycyclische verbindungen und ihre verwendung als antagonisten von metabotropen glutamatrezeptoren | |
DE69716925T2 (de) | Isoxazoline derivate und ihre verwendung als antimikroben | |
ATE481103T1 (de) | Derivate von 2-(8,9-dioxo-2,6- diazabicyclo(5.2.0)non-1(7)-en-2- yl)alkylphosphonsäure und deren verwendung als n- methyl-d-aspartat- (nmda-) rezeptorantagonisten | |
TR200000025T2 (tr) | Azetidinilpropilpiperidin türevleri, ara bağlarıyla tacikinin antagonistleri olarak kullanımları. | |
DE69813605D1 (de) | Benzofuranderivate | |
DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
ATE195516T1 (de) | Substituierte phenylverbindungen als endothelinantagoniste | |
DE59909760D1 (de) | Benzonaphthyridin-n-oxide mit pde3 und pde4 inhibierender aktivität | |
TR200000786T2 (tr) | Vitronektin reseptör antagonisti | |
ATE287886T1 (de) | Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer | |
DE60036558D1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
ATE234098T1 (de) | 4-aminopyrrole (3,2-d) pyrimidinen als antagonisten des neuropeptide y receptors | |
PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
ATE215083T1 (de) | Bicyclische carboxamide als 5-ht1a rezeptoren liganden | |
AR006754A1 (es) | Derivados de quinoxalina utiles en terapia | |
ATE396187T1 (de) | Indolmethyl-n,n'-bisacylpiperazine als neurokininrezeptorantagonisten | |
ATE215935T1 (de) | Heterozyklische verbidungen mit mmp und tnf inhibitorisher wirkung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |